Navigation Links
Princeton Ivy Capital (PICA) announces "Fiscal Cliff Special": Deferred Gains to Minimize tax Liability for clients
Date:12/31/2012

New York, NY (PRWEB) December 31, 2012

PICA's flagship strategy, the "Low Beta Legacy" with its 17-year track record of 14.15% annualized return, also has a long term deferred capital gains feature which prevents capital gains taxes from being incurred. In essence, this allows portfolio gains to grow further tax free as they remain invested for the long term. PICA charges a low fee of 0.5% for all its Clients. Client accounts are protected via "Limited Trading Authority", authorized by Clients.

Read the full story at http://www.prweb.com/releases/2012/12/prweb10279369.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related medicine news :

1. Princeton study reveals the brains mysterious switchboard operator
2. John Templeton Foundation grant supports Princeton neuroscientists to study cognitive control
3. Coca-Cola model for delivering malaria meds is a success, says Princeton researcher
4. Princeton Ivy Capital Advisors has Addressed "Fiscal Cliff Fears" by Using Long Term Strategy for its Investors
5. Seattle Physician Shares Health IT Story in the Nation’s Capital
6. CFO 911 Solutions' Charles K. Dargan II, CEO, and Reid Dabney, Managing Director Have Been Added to the Financial Entrepreneur Platform ("FEP") of Merriman Capital, Inc., a Wholly Owned Subsidiary of Merriman Holdings, Inc. (OTCQX: MERR)
7. Kentucky receives top honors in nations capital for health IT collaboration
8. OutSkirts Press Publishes New Relationship Guide to Help People, Businesses, & Organizations Stretch Their Relationship Capital
9. iTrade Capital Markets/ICM Trading is Now Offering Opportunity to Open a No-Cost Practice Trading Account
10. InnoVative Capital Closes $41 Million FHA 242 Refinancing, Cutting Morehead Memorial Hospital's Loan Rate by 21% and Reducing Debt Service by $5 Million
11. iTrade Capital Markets, ICM Trading Offers Investors an Opportunity to Become a Partner With iTrade Capital Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology: